Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity

被引:36
作者
Achour, Brahim [1 ]
Dantonio, Alyssa [3 ]
Niosi, Mark [3 ]
Novak, Jonathan J. [3 ]
Fallon, John K. [2 ]
Barber, Jill [1 ]
Smith, Philip C. [2 ]
Rostami-Hodjegan, Amin [1 ,4 ]
Goosen, Theunis C. [3 ]
机构
[1] Univ Manchester, Div Pharm & Optometry, Ctr Appl Pharmacokinet Res, Manchester, Lancs, England
[2] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC USA
[3] Pfizer Inc, Dept Pharmacokinet Dynam & Metab, Groton, CT 06340 USA
[4] Simcyp Ltd, Blades Enterprise Ctr, Sheffield, S Yorkshire, England
关键词
IN-VIVO EXTRAPOLATION; ABSOLUTE PROTEIN QUANTIFICATION; RELATIVE EXPRESSION FACTORS; DRUG-METABOLIZING-ENZYMES; INTESTINAL P-GLYCOPROTEIN; CYTOCHROME-P450; ENZYMES; MASS-SPECTROMETRY; SCALING FACTORS; LC-MS/MS; TRANSPORTER PROTEINS;
D O I
10.1124/dmd.117.076703
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantitative characterization of UDP-glucuronosyltransferase (UGT) enzymes is valuable in glucuronidation reaction phenotyping, predicting metabolic clearance and drug-drug interactions using extrapolation exercises based on pharmacokinetic modeling. Different quantitative proteomic workflows have been employed to quantify UGT enzymes in various systems, with reports indicating large variability in expression, which cannot be explained by interindividual variability alone. To evaluate the effect of methodological differences on end-point UGT abundance quantification, eight UGT enzymes were quantified in 24 matched liver microsomal samples by two laboratories using stable isotope-labeled (SIL) peptides or quantitative concatemer (QconCAT) standard, and measurements were assessed against catalytic activity in seven enzymes (n = 59). There was little agreement between individual abundance levels reported by the two methods; only UGT1A1 showed strong correlation [Spearman rank order correlation (Rs) = 0.73, P < 0.0001; R-2 = 0.30; n = 24]. SIL-based abundance measurements correlated well with enzyme activities, with correlations ranging from moderate for UGTs 1A6, 1A9, and 2B15 (Rs = 0.52-0.59, P < 0.0001; R-2 = 0.34-0.58; n = 59) to strong correlations for UGTs 1A1, 1A3, 1A4, and 2B7 (Rs = 0.79-0.90, P < 0.0001; R-2 = 0.69-0.79). QconCAT-based data revealed generally poor correlation with activity, whereas moderate correlations were shown for UGTs 1A1, 1A3, and 2B7. Spurious abundance-activity correlations were identified in the cases of UGT1A4/2B4 and UGT2B7/2B15, which could be explained by correlations of protein expression between these enzymes. Consistent correlation of UGT abundance with catalytic activity, demonstrated by the SIL-based dataset, suggests that quantitative proteomic data should be validated against catalytic activity whenever possible. In addition, metabolic reaction phenotyping exercises should consider spurious abundance-activity correlations to avoid misleading conclusions.
引用
收藏
页码:1102 / 1112
页数:11
相关论文
共 47 条
[41]   Hepatic Uptake of Atorvastatin: Influence of Variability in Transporter Expression on Uptake Clearance and Drug-Drug Interactions [J].
Vildhede, Anna ;
Karlgren, Maria ;
Svedberg, Elin K. ;
Wisniewski, Jacek R. ;
Lai, Yurong ;
Noren, Agneta ;
Artursson, Per .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (07) :1210-1218
[42]   Validated assays for human cytochrome P450 activities [J].
Walsky, RL ;
Obach, RS .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (06) :647-660
[43]   Optimized Assays for Human UDP-Glucuronosyltransferase (UGT) Activities: Altered Alamethicin Concentration and Utility to Screen for UGT Inhibitors [J].
Walsky, Robert L. ;
Bauman, Jonathan N. ;
Bourcier, Karine ;
Giddens, Georgina ;
Lapham, Kimberly ;
Negahban, Andre ;
Ryder, Tim F. ;
Obach, R. Scott ;
Hyland, Ruth ;
Goosen, Theunis C. .
DRUG METABOLISM AND DISPOSITION, 2012, 40 (05) :1051-1065
[44]   Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes [J].
Wegler, Christine ;
Gaugaz, Fabienne Z. ;
Andersson, Tommy B. ;
Wisniewsk, Jacek R. ;
Busch, Diana ;
Groeer, Christian ;
Oswald, Stefan ;
Noren, Agneta ;
Weiss, Frederik ;
Hammer, Helen S. ;
Joos, Thomas O. ;
Poetz, Oliver ;
Achour, Brahim ;
Rostami-Hodjegan, Amin ;
van de Steeg, Evita ;
Wortelboer, Heleen M. ;
Artursson, Per .
MOLECULAR PHARMACEUTICS, 2017, 14 (09) :3142-3151
[45]   Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry [J].
Weiss, Frederik ;
Schnabel, Anke ;
Planatscher, Hannes ;
van den Berg, Bart H. J. ;
Serschnitzki, Bettina ;
Nuessler, Andreas K. ;
Thasler, Wolfgang E. ;
Weiss, Thomas S. ;
Reuss, Matthias ;
Stoll, Dieter ;
Templin, Markus F. ;
Joos, Thomas O. ;
Marcus, Katrin ;
Poetz, Oliver .
SCIENTIFIC REPORTS, 2015, 5
[46]   In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes [J].
Wisniewski, Jacek R. ;
Vildhede, Anna ;
Noren, Agneta ;
Artursson, Per .
JOURNAL OF PROTEOMICS, 2016, 136 :234-247
[47]   Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes [J].
Zientek, Michael A. ;
Youdim, Kuresh .
DRUG METABOLISM AND DISPOSITION, 2015, 43 (01) :163-181